Pulmonary alveolar proteinosis (PAP) is a syndrome characterized by the accumulation of
alveolar surfactant and dysfunction of alveolar macrophages. PAP results in progressive …

Pulmonary alveolar proteinosis (PAP) comprises a heterogenous group of diseases
characterized by abnormal surfactant accumulation resulting in respiratory insufficiency, and …

Pulmonary alveolar proteinosis is a rare syndrome characterized by intra-alveolar
accumulation of surfactant components and cellular debris, with minimal interstitial …

Pulmonary alveolar proteinosis (PAP) is a rare pulmonary disease characterised by alveolar
accumulation of surfactant. It may result from mutations in surfactant proteins or granulocyte …

Pulmonary alveolar proteinosis (PAP) is a diffuse lung disease that results from the
accumulation of lipoproteinaceous material in the alveoli and alveolar macrophages due to …

Pulmonary alveolar proteinosis is a rare but potentially treatable disease, characterized by
impaired surfactant metabolism that leads to accumulation in the alveoli of proteinaceous …

Pulmonary alveolar proteinosis (PAP) is a rare disease characterized by the accumulation of
phospholipids and surfactant proteins in the lung. The central role for granulocyte …

Pulmonary alveolar proteinosis (PAP)(also called alveolar proteinosis, alveolar
phospholipidosis, pulmonary alveolar lipoproteinosis, pulmonary alveolar …

Pulmonary alveolar proteinosis is a rare clinical syndrome that was first described in 1958.
Subsequently, over 240 case reports and small series have described at least 410 cases in …

Pulmonary alveolar proteinosis (PAP) is a rare syndrome of alveolar surfactant
accumulation, resulting hypoxemic respiratory failure, and increased infection risk. Despite …